Results 281 to 290 of about 2,463,634 (361)

Are PROMIS and Legacy Patient-Reported Outcome Measures Correlated for Patients Undergoing Carpal Tunnel Release? [PDF]

J Hand Surg Glob Online
Demetri L, Blazar P, Earp BE, Zhang D.
europepmc   +1 more source

A non‐fluorescent immunohistochemistry method for measuring autophagy flux using MAP1LC3/LC3 and SQSTM1 as core markers

FEBS Open Bio, EarlyView.
We introduce an immunohistochemistry method to measure autophagy flux, highlighting the active degradation and recycling of cellular waste. This cost‐effective approach uses tissue samples to track key markers like LC3 and SQSTM1, revealing how cells maintain health or respond to diseases such as cancer. It bridges the gap between research and clinical
Shahla Shojaei, Amir Barzegar Behrooz, Marco Cordani, Mahmoud Aghaei, Negar Azarpira, Daniel J. Klionsky, Saeid Ghavami   +6 more
wiley   +1 more source

Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience [PDF]

, 2014
Anne Brédart, Alexia Marrel, Linda Abetz-Webb, Kathy Lasch, C. Acquadro   +4 more
openalex   +1 more source

Can Preoperative Patient-reported Outcome Measures Be Used to Predict Meaningful Improvement in Function After TKA?

Clinical Orthopaedics and Related Research, 2017
J. Berliner, D. Brodke, V. Chan, N. SooHoo, K. Bozic   +4 more
semanticscholar   +1 more source

Using artificial intelligence to predict patient outcomes from patient-reported outcome measures: a scoping review. [PDF]

Health Qual Life Outcomes
Wójcik Z, Dimitrova V, Warrington L, Velikova G, Absolom K.   +4 more
europepmc   +1 more source

Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions

FEBS Open Bio, EarlyView.
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik, Deniz Bakkalci, Alexander J. MacRobert, Umber Cheema   +3 more
wiley   +1 more source

Assessing severity of illness and outcomes of treatment in children with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): a systematic review of patient‐reported outcome measures (PROMs) [PDF]

, 2014
Kirstie Haywood, Simon M. Collin, Esther Crawley   +2 more
openalex   +1 more source

Reliability of pre-admission patient-reported outcome measures postoperatively assessed via proxies: a prospective, multicenter observational study. [PDF]

Crit Care
Grunow JJ, Hartmann L, Ulm B, Maechler M, Blobner M, Seidenspinner K, Schoennagel L, Weber-Carstens S, Fuest K, Wollersheim T, Schaller SJ.   +10 more
europepmc   +1 more source

Comparative single‐cell transcriptomic profiling of patient‐derived renal carcinoma cells in cellular and animal models of kidney cancer

FEBS Open Bio, EarlyView.
We generated and characterized clear cell renal cell carcinoma models using the patient‐derived RCC243 cell line—including cell culture, orthotopic, and metastatic tumors—via single‐cell RNA‐sequencing for comparisons between models and patient tumor datasets.
Richard Huang, Lynn Kee, Alexander Gont, Jalna Meens, Fraser G. Ferens, Meredith S. Irwin, Laurie Ailles, Scott A. Yuzwa, Claire M. Robinson, Michael Ohh   +9 more
wiley   +1 more source

The Family Reported Outcome Measure (c): initial validation of a generic QoL measure for family members of patients with chronic medical conditions [Abstract] [PDF]

, 2012
Catherine Jane Golics, Mohamed K. A. Basra, Mir-saeed Salek, A.Y. Finlay   +3 more
openalex